金活醫藥集團(01110.HK):珠海金明與餘仁生香港就保嬰丹訂立獨家分銷協議
格隆匯4月7日丨金活醫藥集團(01110.HK)公吿,於2022年3月31日,珠海市金明醫藥有限公司("珠海金明",公司全資附屬公司擁有50%的合營企業,且為中國內地一家醫藥保健品分銷商)與餘仁生(香港)有限公司("餘仁生香港",一家於香港成立的公司)訂立獨家分銷協議,內容有關在中華人民共和國廣東省及福建省從事保嬰丹("該產品")的進口、推廣、採購、分銷及銷售。
根據該協議,餘仁生委任珠海金明為其在中國廣東省及福建省的獨家分銷商,負責通過雙方約定的線下渠道及指定線上渠道進行該產品的進口、推廣、採購、分銷及銷售,初步年期為三年,自2022年4月1日起生效。三年的初步年期屆滿後,該協議可以續期,但須滿足該協議中所載列的若干條件。
集團主要於中國及香港從事(i)品牌進口醫藥及保健產品的分銷,及(ii)製造及銷售電療及物療設備及一般醫療檢查設備。集團的目標為,利用其商業平台、龐大的分銷網絡和多樣的營銷策略,最大程度挖掘該產品的價值及市場潛力。
董事會認為,訂立該協議將進一步擴大集團的產品組合及鞏固其市場地位,充分利用中國蓬勃發展的市場中消費者對醫藥產品不斷增長的需求,此舉將對本集團及本公司股東整體有利。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.